ReviewCommunications biology2026
Hepatitis E virus genome plasticity: a marker of chronicity and therapy failure?
Review in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Hepatitis E virus (HEV) is a globally distributed zoonotic pathogen, spread by contaminated food and blood products, and a leading cause of acute viral hepatitis. Recent data indicate that the HEV genome contains a highly heterogeneous hypervariable region (HVR) that can tolerate extensive genomic rearrangements, especially among immunocompromised patients. These rearrangements can increase HEV replication in tissue-culture and have further been observed in HEV-infected patients. Insertions comprise either duplications of virus-derived sequences, or alternatively, host-derived sequence fragments and exhibit enrichment of specific amino acids and functional motifs. However, the molecular mechanisms driving these insertions, as well as their functional significance, remain largely unexplored. Given that sequences not required for infectivity or replication are typically rapidly eliminated in small RNA viruses such as HEV, the persistence of HVR insertions suggests a potential biological role in HEV replication and/or pathogenesis. This review summarizes our current understanding of the role of HVR insertions during HEV infection, as well as the potential mechanisms underlying these insertions. We further discuss the factors driving the selection of genomic insertions and speculate on their functional role by analyzing over 650 publicly available HEV genotype 3 genome sequences and systematically cataloging identified insertions.
Indexed as
Identifiers
42918835What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.